[ad_1]
VšZP terminated its contract with two companies, Medirex and Medicyt, on May 31st. According to VšZP, both companies raised such financial demands in the negotiations, which the insurance company could not fulfill. The Ministry of Health is monitoring the situation. A meeting on the eventual renewal of the agreement with companies was held Monday. Other negotiations are ongoing today.
Resumption of negotiations
The state of VšZP wanted to reach an agreement with Medirex and Medicyt on Monday to provide laboratory diagnostics. Both parties were negotiating in the morning. "The partners have expressed their desire to renew the contractual relationship. They would like to reach an agreement today ", said Jana Martanovičová, VšZP's communications officer. However, no agreement has been reached on the negotiations of yesterday.
Source: TASR / Pavol Zachar
"The continuation of negotiations is scheduled for today" told Topky Martanovičová. The insurance company will inform the results as soon as possible. Laboratory representatives have identified constructive discussions to date. "We are moving towards an agreement on the terms of the new treaty from June 2019. We are waiting for a new treaty proposal", Diana Madarászová told the spokesperson of the group Medirex, Diana.
People are worried about loading
As soon as this report spread, many people started to echo. They are afraid of having to pay their subscriptions. Some patients refused to take blood at the beginning of the week and others had to pay. "Today, I paid 50 euros for subscriptions as a deposit, and I will pay anyway", one of the dissatisfied patients reported.
Demanding financial needs
The contracts with both companies were terminated on the last day of May. The reason was the financial requirements. "Companies that provide laboratory diagnostics have raised such financial demands in the negotiations, which VšZP has not been able to satisfy," insurer in the minutes. Thus, both companies should be reimbursed by VŠZP for laboratory examinations carried out only as part of urgent health care after approval.
Source: TASR / Pavol Zachar
"We assume that the reimbursement of laboratory exams will be almost 100% for insured persons hospitalized in health facilities. Medirex and Medicyt will not reimburse VšZP for laboratory diagnostics performed as part of preventative and suspensive health care, " she wrote in the press room on Friday. Health care providers requested that laboratory samples be sent to other VšZP contractual partners.
The insurance company aims to resume negotiations
Health Minister Andrea Kalavská has asked to resume negotiations this weekend. The health sector is monitoring the situation. Ľubica Hlinková, General Manager of the General Insurance Company, informed the Minister of Health, Andrea Kalavská, of negotiations underway yesterday. She assured the head of the Ministry of Health that the insurance company would enter into an agreement with the company in question.
Source: TASR / Jakub Kotian
"The patient is a priority for the minister, health care providers and health insurance companies, according to Kalavská, must work in such a way that the patient at the clinic or at the hospital does not do not feel the hearing and get everything he is entitled to Spokesperson Zuzana Eliášová.
Bad financing of the sector
At the same time, the ministry has set up a working group to analyze the possibility of creating a public limited company. The goal is to make laboratory investigation methods in the hands of the state in the future. "The station is systematically working on the measures to be taken to prevent individuals from entering public health facilities", ozrejmila Eliášová. For example, most state hospitals already run their own pharmacies.
"Today, VšZP bears the consequences of poorly adjusted funding from the health sector. We do not want such a development, we do not want the insured to bear the consequences of the instability of the sector and believe in a quick correction ", the insurance company added in his opinion. VšZP also tries to contribute to efficiency by implementing the Value for Money austerity measures in order to stabilize the economic situation for the future.
[ad_2]
Source link
